Trial intelligence / Profile preview

Food effect and itraconazole interaction study of JNJ-67953964 in healthy adults

NL-OMON49179Completed

Sponsor
Janssen Pharmaceutical
Start
Mar 2020
Modality
Small Molecules
Countries
1
01

Overview

Randomised, open-label trial of aticaprant in major depressive disorder (MDD), sponsored by Janssen Pharmaceutical. Started Mar 2020; status: completed.

02

Drugs

aticaprant
03

Conditions

major depressive disorder (MDD)

Beyond the preview

Go deeper on NL-OMON49179.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON49179.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call